Patent · US Active

Levodopa prodrug mesylate hydrate

US8722733B2 · kind B2 · utility

0Cited by

52References

19Claims

0Family size

Assignee

XENOPORT, INC. · US

Inventors

Sami Karaborni · Cupertino, US
Manshiu Leung · Daly City, US
Chen Mao · Shanghai, CN
Venkat R. Thalladi · Foster City, US

Key dates

Filing date	Feb 18, 2013
Grant date	May 13, 2014
Priority date	—
Expiry date	Feb 18, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Crystalline (2R)-2-phenylcarbonyloxypropyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate mesylate, hydrate, methods of making the hydrate, pharmaceutical compositions containing the hydrate, and methods of using the hydrate to treat diseases or disorders such as Parkinson's disease are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.